Accele BioPharma, Inc.

New Filing

CIK: 0001556986·Other Health Care·OKLAHOMA·Filed: Sep 4, 2012

Total Offering

$2,600,639

Amount Sold

$2,600,639

Investors

6

First Sale

Aug 21, 2012

Offering Details

Type: Equity
Exemptions: Rule 506
Entity Type: Corporation
Year Incorporated: 2012
Non-Accredited Investors: No

Related Persons

Name	Role
Clayton Duncan
Carl Edwards
Stephen Prescott

Company

Accele BioPharma, Inc.

655 RESEARCH PARKWAY

OKLAHOMA CITY, OK, 74104

919-360-7010

SEC Filing

0001556986-12-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.